Construction and identification of recombinant human bone morphogenetic protein-2 gene adenoviral vector
Liang-quan Peng,Da-ping Wang,Ke Zhou,Jun-feng Huang,Kai Ren,Xiao-ping Xu,Wei Lu,Jian-yi Xiong,Kan Ouyang,Wei-ming Zhu
DOI: https://doi.org/10.3969/j.issn.1673-8225.2009.20.030
2009-01-01
Abstract:BACKGROUND: Previous studies regarding recombinant adenovirus is characterized by complicated construction method with long period, which lead to low success rate. By using site-specific recombination, Gateway™ technique can construct recombinant virus vector effectively and rapidly. OBJECTIVE: To construct recombinant adenovirus vector carrying human bone morphogenetic protein-2 (hBMP-2), in order to provide a basis for the research of gene therapy. DESIGN, TIME AND SETTING: A single sample observation was performed at the Central Laboratory of Shenzhen Second People's Hospital between February and June 2008. MATERIALS: pOTB7-BMP-2 plasmid, HEK293 was produced by ATTC. BLOCK-iT™ Adenovirus Expression System was purchased from Invitrogen Company. E. coli DH5α was supplied by Biontex. METHODS: BMP-2cDNA was amplified by PCR, and then inserted into cloning vector pMD19-T Simple Vector. The BMP-2cDNA was subcloned into a shuttle vector and the recombinant pEC3.1-BMP2 vector was obtained. It was subcloned into pAd/BLOCK-iT™-DEST adenoviral genomic and linearization transfection 293 cell package to obtain Ad-BMP2. MAIN OUTCOME MEASURES: Circled digit oneAmplification of BMP-2 by PCR. Circled digit twoConstruction of recombinant plasmid TS-BMP2, pEC3.1-BMP2 and pAd-BMP2. Circled digit threePreparation and identification of recombinant adenovirus. RESULTS: A length of 1 200 bp BMP-2 cDNA was amplified, which was subcloned into adenoviral vector, linearizing pAd-BMP2 DNA followed by transfected HEK293 cells and the rAd-BMP2 was obtained. The titre of virus was 1×1010 PFU/mL, which could meet the need of research of BMP2 osteogenesis. CONCLUSION: The hBMP-2 recombinant adenovirus is constructed successfully.